UTHR Sale Disclosure
Rothblatt Martine A · SEC Form 4 · Filed Oct 23, 2026
Sale
Calculated transaction value
$92.57K
Rothblatt Martine A Chairperson & CEO
UTHR
Transaction date
Oct 22, 2026
Public filing date
Oct 23, 2026
Filing lag
Filed 1 day later
UTHR daily price context
Close on/before transaction
$584.79
Oct 22, 2026
First close after public filing
$592.84
Oct 26, 2026
Return after filing · so far
-1.75%
Through Nov 9, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 160 shares @ $578.59
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001106578-26-000170
Filing cohort
Transactions in this filing
Showing 15 of 23
Trades
23
Issuers
1
Estimated value
$6.66M
Buys / sales
0 / 21
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| United Therapeutics Corp UTHR | Sale | Oct 22, 2026 | $90.41K |
| United Therapeutics Corp UTHR Current | Sale | Oct 22, 2026 | $92.57K |
| United Therapeutics Corp UTHR | Sale | Oct 22, 2026 | $92.75K |
| United Therapeutics Corp UTHR | Sale | Oct 22, 2026 | $91.21K |
| United Therapeutics Corp UTHR | Sale | Oct 22, 2026 | $91.48K |
| United Therapeutics Corp UTHR | Sale | Oct 22, 2026 | $22.94K |
| United Therapeutics Corp UTHR | Sale | Oct 22, 2026 | $750.47K |
| United Therapeutics Corp UTHR | Exercise | Oct 22, 2026 | $0 |
| United Therapeutics Corp UTHR | Sale | Oct 22, 2026 | $41.66K |
| United Therapeutics Corp UTHR | Sale | Oct 22, 2026 | $74.79K |
| United Therapeutics Corp UTHR | Sale | Oct 22, 2026 | $109.59K |
| United Therapeutics Corp UTHR | Sale | Oct 22, 2026 | $161.64K |
| United Therapeutics Corp UTHR | Sale | Oct 22, 2026 | $209.17K |
| United Therapeutics Corp UTHR | Sale | Oct 22, 2026 | $232.73K |
| United Therapeutics Corp UTHR | Sale | Oct 22, 2026 | $443.15K |